scholarly journals Functional status of very old people in urban area: The Itabashi Oldest-Old Study I

2005 ◽  
Vol 42 (2) ◽  
pp. 199-208 ◽  
Author(s):  
Yasuyuki Gondo ◽  
Taketo Furuna ◽  
Erika Kobayashi ◽  
Hiroki Inagaki ◽  
Miho Sugiura ◽  
...  
2010 ◽  
Vol 60 (4) ◽  
pp. 301-325 ◽  
Author(s):  
Christian J. Lalive d'Epinay ◽  
Stefano Cavalli ◽  
Luc A. Guillet

This article deals with the following two questions: In very old age, which are the main sources of bereavement? And what are the consequences of such losses on health and on relationships? The findings are based on the complete set of data compiled in the course of the Swiss Interdisciplinary Longitudinal Study on the Oldest Old (SWILSOO), which provided a 10-year follow-up of a first cohort (1994–2004) and a 5-year follow-up of a second (1999–2004). The data revealed that, in very old age, the great majority of the dear ones who died were either siblings or close friends. Taken as a whole, the bereaved suffered a marked and lasting increase in depressive symptoms, together with a short-term deterioration in their functional status; those bereft of a spouse or a child saw their functional status worsen and exhibited enduring depressive symptoms but they also benefited from support in the form of increased interaction; those bereft of siblings only suffered from a mild, short-term deterioration in functional status; those who had lost a close friend suffered a very significant increase in depressive symptoms. In the medium term, most of these effects disappeared, lending weight to the claim that the survivors manage to cope with the misfortunes of life.


2006 ◽  
Vol 18 (6) ◽  
pp. 497-502 ◽  
Author(s):  
Margareta Westerbotn ◽  
Pernilla Hillerås ◽  
Johan Fastbom ◽  
Hedda Agüero-Torres

2019 ◽  
Vol 3 (Supplement_1) ◽  
pp. S868-S868
Author(s):  
Marja Jylha ◽  
Jani Raitanen ◽  
Kristina Tiainen ◽  
Pauliina Halonen ◽  
Linda Enroth

Abstract Reliable population-based data on health, functioning and quality of life among very old people are scarce because only during the last decades this age group has grown to be an important segment of population, and because data collection among the oldest old is challenging. Due to poor health, problems in hearing and vision, cognitive decline, and institutionalization, very old individuals may not be able to participate in research studies, or, the information they give may not be reliable. In the Vitality 90+ Study, the whole population aged 90+ in the Tampere area, Finland, has been investigated six times since 2001. Mailed surveys have been conducted in years 1995, 1996, 1998, 2001, 2003, 2007, 2010, 2014, and 2018. In each data collection, the response rate has been ca 80%. The questionnaires and the wording of the questions have been identical in each survey round, which provides data for investigating time trends in health, functioning, and quality of life. Linkages with national population and care registers are used for studying mortality and care use. In this poster, we analyze the impact of 1) exhaustive base data, 2) the questionnaire, 3) including institutionalized individuals and proxy answers, on the findings and on the quality and reliability of the data. We conclude that mailed surveys can be a feasible method of data collection among very old people, but only in favorable local circumstances and with great efforts from the research group.


1997 ◽  
Vol 17 (6) ◽  
pp. 713-725 ◽  
Author(s):  
EMILY GRUNDY

This paper provides a brief introduction to demography and population science and the newly emerged subfield of the demography of ageing. Links with gerontology are explored. Recent work on mortality at very high ages and on the black-white mortality ‘cross-over’ reported from the United States is then reviewed. These topics are important substantively and theoretically and also serve to illustrate demographic approaches to data and data analysis. Analytic approaches to the topics reviewed have had to be imaginative as there are major problems with data on very old people. Recent work indicates that the mortality of very old people, including centenarians, has fallen considerably, at least in those countries where good data exist. The mortality ‘cross-over’, however, appears to be artefactual, at least at ages under 95 years.


2005 ◽  
Vol 42 (2) ◽  
pp. 214-220 ◽  
Author(s):  
Hajime Iwasa ◽  
Yasuyuki Gondo ◽  
Taketo Furuna ◽  
Erika Kobayashi ◽  
Hiroki Inagaki ◽  
...  

2006 ◽  
Vol 7 (3) ◽  
pp. 78-79
Author(s):  
O.D. Vasovic ◽  
L.J. Zikic ◽  
G. Sevo ◽  
M. Zamaklar ◽  
D. Milosevic

2007 ◽  
Vol 62 (6) ◽  
pp. 636-640 ◽  
Author(s):  
U. Lindemann ◽  
R. Muche ◽  
M. Stuber ◽  
W. Zijlstra ◽  
K. Hauer ◽  
...  
Keyword(s):  
Very Old ◽  

Stroke ◽  
2017 ◽  
Vol 48 (suppl_1) ◽  
Author(s):  
Matthew Alcusky ◽  
Anne L Hume ◽  
Kate L Lapane

Background: The net health benefit of statin use in the oldest patients remains controversial. Preclinical models and previous clinical studies have suggested statins may exhibit neuroprotective effects in stroke, however evidence in the very old remains limited. Our objective was to compare changes in functional status before and after acute ischemic stroke (AIS) between statin users and non-users in a national cohort. Methods: A patient’s first hospitalization for AIS from 04/01/11 to 12/31/2012 was selected from Medicare Part A claims. Patients with a pre-hospitalization nursing home Minimum Data Set assessment and a post-hospitalization assessment in a skilled nursing facility were included. Pre-stroke statin exposure was defined using Part D claims. Functional status was measured continuously and categorically (dependent:<20, partially dependent(PD):20-59, assisted independent(AI):60-100) using Shah’s modified Barthel Index (mBI). Multivariable logistic regression examined the association of statins with a minimum clinically important mBI decrease of 10 points among non-dependent patients. Results: Among 10,203 patients with an assessment before hospitalization, 7.2% died, and 48.7% were included (mean age: 83.6±9.6; 74.5% women). Statin use was common (36.5%), while acute treatment was infrequent (thrombolysis: 4.9%; thrombectomy: 0.1%). The distribution of functional dependence, PD, and AI shifted from 17.3%, 56.1%, and 26.7% at baseline to 49.7%, 44.4%, and 5.9% post-stroke, respectively. A consistent association with 10-point mBI decline was observed for statin exposure among all non-dependent (OR: 0.8; 95%CI: 0.7-1.0) and within strata of PD (OR:0.8; 95%CI: 0.7-1.0) and AI patients (OR: 0.8; 95%CI: 0.5-1.3). In contrast, acute treatment was more strongly associated with function in AI (OR: 0.5; 95%CI: 0.2-1.0) versus PD patients (OR: 1.0; 95%CI: 0.7-1.5). Conclusion: In this high-burden population, our results are suggestive of a possible protective association for pre-stroke statin exposure. Further research is needed to examine temporal and dose-response relationships between statin exposure and functional outcomes across diverse patient populations.


Sign in / Sign up

Export Citation Format

Share Document